Stocks · News reference

USANA Extends Nordiq Canada Partnership Through 2030 Winter Games

Jul 20, 2026, 11:19 AMBenzinga Newsdesk

USANA Health Sciences, Inc. (NYSE:USNA), a global leader in science-based nutrition, today announced a renewal of its official partnership with Nordiq Canada, the national governing body for cross-country skiing in

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

USNA

Source: benzinga
Observed: Jul 20, 2026, 11:19 AM
Checked: Jul 20, 2026, 11:19 AM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

SEC EDGAROct 5, 2026, 8:36 PMSEC EDGAR
8-K filing — USANA HEALTH SCIENCES INC (USNA)
Filed: 2026-10-05 AccNo: 0000896264-26-000060 Size: 188 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits
USNA
BenzingaAug 5, 2026, 12:11 PMBenzinga Newsdesk
Usana Health Sciences shares are trading lower after the company reported worse-than-expected Q2 financial results. Also, the company cut its FY26 guidance below estimates.
USNA
BenzingaAug 4, 2026, 8:56 PMBenzinga Newsdesk
Usana Health Sciences Lowers FY2026 Adj EPS Guidance from $1.95-$2.29 to $0.76 vs $2.12 Est; Lowers FY2026 Sales Guidance from $925.000M-$1.000B to $910.000M vs $945.097M Est
Usana Health Sciences (NYSE:USNA) lowers FY2026 Adj EPS guidance from $1.95-$2.29 to $0.76 vs $2.12 analyst estimate. Lowers FY2026 sales outlook from $925.000 million-$1.000 billion to $910.000 million vs $945.097
USNA
BenzingaAug 4, 2026, 8:36 PMBenzinga Newsdesk
Usana Health Sciences shares are trading lower after the company reported worse-than-expected Q2 financial results.
USNA

USANA Extends Nordiq Canada Partnership Through 2030 Winter Games

Connected Markets

Related Headlines

8-K filing — USANA HEALTH SCIENCES INC (USNA)

Usana Health Sciences shares are trading lower after the company reported worse-than-expected Q2 financial results. Also, the company cut its FY26 guidance below estimates.

Usana Health Sciences Lowers FY2026 Adj EPS Guidance from $1.95-$2.29 to $0.76 vs $2.12 Est; Lowers FY2026 Sales Guidance from $925.000M-$1.000B to $910.000M vs $945.097M Est

Usana Health Sciences shares are trading lower after the company reported worse-than-expected Q2 financial results.